Drug · DIN 02330571
SUMATRIPTAN INJECTION
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since July 29, 2021.
- Drug Identification Number (DIN)
- 02330571
- Company (DIN owner)
- Teva Canada LimitedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Sumatriptan N02CC01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SUMATRIPTAN (SUMATRIPTAN SUCCINATE) | 12 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 28, 2011: NOC 12470Abbreviated New Drug Submission (ANDS) · Manufacturer and product name change
- July 31, 2009: NOC 10458Supplement to an Abbreviated New Drug Submission (SANDS) · New dosage form